Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Black Diamond Therapeutics Inc | BDTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.11 | 06:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.11 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.43 - 6.85 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 5.11 | USD |
Black Diamond Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 264.28M | 51.72M | - | 0 | -82.44M | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Black Diamond Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BDTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.17 | 5.57 | 4.87 | 5.09 | 369,309 | -0.06 | -1.16% |
| 1 Month | 5.21 | 6.21 | 4.56 | 5.25 | 493,207 | -0.10 | -1.92% |
| 3 Months | 4.21 | 6.21 | 3.57 | 4.85 | 607,759 | 0.90 | 21.38% |
| 6 Months | 1.92 | 6.21 | 1.62 | 3.76 | 542,712 | 3.19 | 166.15% |
| 1 Year | 1.50 | 6.85 | 1.43 | 5.21 | 1,432,606 | 3.61 | 240.67% |
| 3 Years | 26.62 | 29.02 | 1.18 | 5.95 | 688,344 | -21.51 | -80.80% |
| 5 Years | 33.00 | 46.25 | 1.18 | 9.42 | 566,016 | -27.89 | -84.52% |
Black Diamond Therapeutics Description
| Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under pipeline are BDTX-189 and BDTX-1535. |
